Advertisement

Topics

ReGen therapeutics Plc Company Profile

11:07 EDT 25th September 2017 | BioPortfolio

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex isolated from ovine colostrinin. Colostrum is the mammal's first milk after the birth of an offspring.

Location

6 Chelmsford Road, South Woodford
London
London
E18 2PL
United Kingdom

Contact

Phone: 0208 504 2156
Fax: 0208 504 2156
Email: lomax.pharma@lineone.net


News Articles [1551 Associated News Articles listed on BioPortfolio]

Regen BioPharma Addresses Potential Impact of Recent Bristol-Myers Squibb's $2.3 Billion Acquisition Of IFM Therapeutics

  Life Sciences Jobs   ...

Regen BioPharma Addresses Potential Impact Of Recent Bristol-Myers Squibb $2.3 Billion Acquisition Of IFM Therapeutics

  Life Sciences Jobs   ...

Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb $2.3 Billion Acquisition of IFM Therapeutics

SAN DIEGO, August 9, 2017 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) sees recent deal activity in the immune oncology space as an indication that big pharma continues to...

Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb's $2.3 Billion Acquisition of IFM Therapeutics

SAN DIEGO, August 10, 2017 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) sees recent deal activity in the immune oncology space as an indication that big pharma continues t...

Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb's $2. ...

On August 3, 2017Bristol Myers Squibb (BMS) announced that it had entered into an agreement to acquire IFM Therapeutics, a smaller biotech company focused Read more...

Zander Therapeutics, Inc. Reports Research Demonstrating Ex-Vivo Immune Suppression of IL-17a and IL-2 in Dogs With Novel NR2F6 Activators

SAN DIEGO, July 26, 2017 /PRNewswire/ -- Zander Therapeutics, Inc., a subsidiary of Entest BioMedical Inc. (OTCPINK: ENTB) reported that researchers for Regen BioPharma Inc. have identified what t...

Entest BioMedical Inc. Subsidiary Zander Therapeutics Discusses Developments in Medicinal Chemistry for Veterinary Applications of Cancer and Autoimmune Therapies Through Modulation of Checkpoint NR2F6

SAN DIEGO, May 23, 2017 /PRNewswire/ -- Entest BioMedical Inc. (PINK: ENTB) and Its subsidiary, Zander Therapeutics Inc., discussed recently reported progress achieved by Regen BioPharma Inc. (lic...

Regen BioPharma, Inc. Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint

SAN DIEGO, July 12, 2017 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), today reported continued progress in developing small molecule drugs that activate and inhibit NR2F6...

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty

Autologous glue therapy with platelet-rich plasma (PRP) was reported to improve outcomes in plastic surgery. However, only pilot studies and retrospective uncontrolled trials have reported...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1151 Associated Companies listed on BioPortfolio]

ReGen therapeutics Plc

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. ...

ReGen Biologics

ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue repair products for U.S. and global markets.ReGen's patented collagen scaffold technology in...

ReGen Biologics, Inc.

Ennova Direct, Inc.

Ennova Direct, Inc. (http://www.ennovadirect.com) was founded in 2003 by Paul Regen and Peter Garrett, and is located at the northern end of the Monterey Bay in Scotts Valley, CA....

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "ReGen therapeutics Plc" on BioPortfolio

We have published hundreds of ReGen therapeutics Plc news stories on BioPortfolio along with dozens of ReGen therapeutics Plc Clinical Trials and PubMed Articles about ReGen therapeutics Plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReGen therapeutics Plc Companies in our database. You can also find out about relevant ReGen therapeutics Plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record